Pharmacyclics (United States)

491 papers and 20.9k indexed citations i.

About

In recent decades, authors affiliated with Pharmacyclics (United States) have published 491 papers, which have received a total of 20.9k indexed citations. Scholars at this organization have produced 304 papers in Genetics, 178 papers in Pathology and Forensic Medicine and 111 papers in Molecular Biology on the topics of Chronic Lymphocytic Leukemia Research (284 papers), Lymphoma Diagnosis and Treatment (172 papers) and Chronic Myeloid Leukemia Treatments (78 papers). Their work is cited by papers focused on Genetics (10.5k citations), Pathology and Forensic Medicine (8.1k citations) and Molecular Biology (5.6k citations). Authors at Pharmacyclics (United States) collaborate with scholars in United States, United Kingdom and Italy and have published in prestigious journals including New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society. Some of Pharmacyclics (United States)'s most productive authors include Joseph J. Buggy, Richard A. Miller, Jonathan L. Sessler, Betty Chang, Markus F. Renschler, Jan A. Burger, Darren Magda, Mint Sirisawad, Tarak D. Mody and Erik Verner.

In The Last Decade

Fields of papers published by authors at Pharmacyclics (United States)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Pharmacyclics (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Pharmacyclics (United States) at the time of their publication.

Countries citing scholars working at Pharmacyclics (United States)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Pharmacyclics (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Pharmacyclics (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pharmacyclics (United States) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025